OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 317
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 317
Showing 26-50 of 317 citing articles:
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Manoj Garg, Muthu K. Shanmugam, Vipul Bhardwaj, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1291-1336
Closed Access | Times Cited: 113
Manoj Garg, Muthu K. Shanmugam, Vipul Bhardwaj, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1291-1336
Closed Access | Times Cited: 113
Phytochemicals as Anti-Inflammatory Agents in Animal Models of Prevalent Inflammatory Diseases
Seong A. Shin, Byeong Jun Joo, Jun Seob Lee, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5932-5932
Open Access | Times Cited: 110
Seong A. Shin, Byeong Jun Joo, Jun Seob Lee, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5932-5932
Open Access | Times Cited: 110
Rationalizing the therapeutic potential of apigenin against cancer
Semim Akhtar Ahmed, Parama Dey, Enush Daimari, et al.
Life Sciences (2020) Vol. 267, pp. 118814-118814
Closed Access | Times Cited: 89
Semim Akhtar Ahmed, Parama Dey, Enush Daimari, et al.
Life Sciences (2020) Vol. 267, pp. 118814-118814
Closed Access | Times Cited: 89
JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition
Yiming Luo, Madison Alexander, Massimo Gadina, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 4, pp. 911-925
Open Access | Times Cited: 86
Yiming Luo, Madison Alexander, Massimo Gadina, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 4, pp. 911-925
Open Access | Times Cited: 86
Celastrol in cancer therapy: Recent developments, challenges and prospects
Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Cancer Letters (2021) Vol. 521, pp. 252-267
Closed Access | Times Cited: 80
Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Cancer Letters (2021) Vol. 521, pp. 252-267
Closed Access | Times Cited: 80
Nanoparticles Targeting STATs in Cancer Therapy
Milad Ashrafizadeh, Zahra Ahmadi, Niranjan G. Kotla, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1158-1158
Open Access | Times Cited: 76
Milad Ashrafizadeh, Zahra Ahmadi, Niranjan G. Kotla, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1158-1158
Open Access | Times Cited: 76
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
Daniel Doheny, Sherona Sirkisoon, Richard L. Carpenter, et al.
Oncogene (2020) Vol. 39, Iss. 42, pp. 6589-6605
Open Access | Times Cited: 70
Daniel Doheny, Sherona Sirkisoon, Richard L. Carpenter, et al.
Oncogene (2020) Vol. 39, Iss. 42, pp. 6589-6605
Open Access | Times Cited: 70
Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer
Indranil Chattopadhyay, Rangarao Ambati, Rohit Gundamaraju
Mediators of Inflammation (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 66
Indranil Chattopadhyay, Rangarao Ambati, Rohit Gundamaraju
Mediators of Inflammation (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 66
Gestational Diabetes Mellitus: The Crosslink among Inflammation, Nitroxidative Stress, Intestinal Microbiota and Alternative Therapies
Elaine Luiza Santos Soares de Mendonça, Marilene Brandão Tenório Fragoso, Jerusa Maria de Oliveira, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 129-129
Open Access | Times Cited: 60
Elaine Luiza Santos Soares de Mendonça, Marilene Brandão Tenório Fragoso, Jerusa Maria de Oliveira, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 129-129
Open Access | Times Cited: 60
Xanthohumol from Hop: Hope for cancer prevention and treatment
Sosmitha Girisa, Queen Saikia, Devivasha Bordoloi, et al.
IUBMB Life (2021) Vol. 73, Iss. 8, pp. 1016-1044
Open Access | Times Cited: 59
Sosmitha Girisa, Queen Saikia, Devivasha Bordoloi, et al.
IUBMB Life (2021) Vol. 73, Iss. 8, pp. 1016-1044
Open Access | Times Cited: 59
Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
Ronan Thibaut, Matthew Gage, Inès Pineda‐Torra, et al.
FEBS Journal (2021) Vol. 289, Iss. 11, pp. 3024-3057
Open Access | Times Cited: 56
Ronan Thibaut, Matthew Gage, Inès Pineda‐Torra, et al.
FEBS Journal (2021) Vol. 289, Iss. 11, pp. 3024-3057
Open Access | Times Cited: 56
Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy
Umme Hani, Riyaz Ali M. Osmani, Sabina Yasmin, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1576-1576
Open Access | Times Cited: 44
Umme Hani, Riyaz Ali M. Osmani, Sabina Yasmin, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1576-1576
Open Access | Times Cited: 44
STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
Mingjing Jiang, Bo Li
Cells (2022) Vol. 11, Iss. 19, pp. 3131-3131
Open Access | Times Cited: 43
Mingjing Jiang, Bo Li
Cells (2022) Vol. 11, Iss. 19, pp. 3131-3131
Open Access | Times Cited: 43
Precision medicine: Ray of hope in overcoming cancer multidrug resistance
Pankaj Musyuni, Jing Bai, Afsana Sheikh, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100889-100889
Closed Access | Times Cited: 40
Pankaj Musyuni, Jing Bai, Afsana Sheikh, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100889-100889
Closed Access | Times Cited: 40
Roles of STAT3 in the pathogenesis and treatment of glioblastoma
Weijia Fu, Xue Hou, Lihua Dong, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 30
Weijia Fu, Xue Hou, Lihua Dong, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 30
Understanding mechanistic aspects and therapeutic potential of natural substances as anticancer agents
Aakash Deep, Davinder Kumar, Nitin Bansal, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100418-100418
Open Access | Times Cited: 26
Aakash Deep, Davinder Kumar, Nitin Bansal, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100418-100418
Open Access | Times Cited: 26
The Role and Mechanism of Metformin in Inflammatory Diseases
Huan Lin, Haiyong Ao, Guang‐hua Guo, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5545-5564
Open Access | Times Cited: 22
Huan Lin, Haiyong Ao, Guang‐hua Guo, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5545-5564
Open Access | Times Cited: 22
Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression
Omid Rahbar Farzam, Souzan Najafi, Mohammad Amini, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Omid Rahbar Farzam, Souzan Najafi, Mohammad Amini, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Inflammation and cancer: friend or foe?
Andrés David Turizo-Smith, Samantha Córdoba-Hernandez, Lidy Vannessa Mejía-Guarnizo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Andrés David Turizo-Smith, Samantha Córdoba-Hernandez, Lidy Vannessa Mejía-Guarnizo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Etiology of lung carcinoma and treatment through medicinal plants, marine plants and green synthesized nanoparticles: A comprehensive review
Priya Chaudhary, Pracheta Janmeda, Aaushi Pareek, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116294-116294
Open Access | Times Cited: 11
Priya Chaudhary, Pracheta Janmeda, Aaushi Pareek, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116294-116294
Open Access | Times Cited: 11
Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics
Manish Kumar
(2025)
Closed Access | Times Cited: 1
Manish Kumar
(2025)
Closed Access | Times Cited: 1
Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
Jong Hyun Lee, Shobith Rangappa, Chakrabhavi Dhananjaya Mohan, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 550-550
Open Access | Times Cited: 74
Jong Hyun Lee, Shobith Rangappa, Chakrabhavi Dhananjaya Mohan, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 550-550
Open Access | Times Cited: 74
LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway
Young Yun Jung, Jeong‐Hyeon Ko, Jae‐Young Um, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5253-5264
Closed Access | Times Cited: 68
Young Yun Jung, Jeong‐Hyeon Ko, Jae‐Young Um, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5253-5264
Closed Access | Times Cited: 68
The vital role of ATP citrate lyase in chronic diseases
Amrita Devi Khwairakpam, Kishore Banik, Sosmitha Girisa, et al.
Journal of Molecular Medicine (2019) Vol. 98, Iss. 1, pp. 71-95
Closed Access | Times Cited: 64
Amrita Devi Khwairakpam, Kishore Banik, Sosmitha Girisa, et al.
Journal of Molecular Medicine (2019) Vol. 98, Iss. 1, pp. 71-95
Closed Access | Times Cited: 64
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
Grégory La Sala, Camille Michiels, Tim Kükenshöner, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 60
Grégory La Sala, Camille Michiels, Tim Kükenshöner, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 60
